172 related articles for article (PubMed ID: 31567119)
1. Toggle Malapposition and Femoral Subocclusion as a Potential Complication of Manta Closure Device During TAVR.
Díez-Delhoyo F; Elizaga J; Gutierrez-Ibañes E; Fernández-Aviles F
J Invasive Cardiol; 2019 Oct; 31(10):E300. PubMed ID: 31567119
[TBL] [Abstract][Full Text] [Related]
2. Occlusion following the deployment of MANTA VCD after TAVR.
Hassan MF; Mixon T; Gray WT; Reddy R
J Card Surg; 2020 Nov; 35(11):3148-3149. PubMed ID: 32939801
[TBL] [Abstract][Full Text] [Related]
3. Impact of percutaneous femoral arteriotomy closure using the MANTA
De Palma R; Settergren M; Rück A; Linder R; Saleh N
Catheter Cardiovasc Interv; 2018 Nov; 92(5):954-961. PubMed ID: 29575678
[TBL] [Abstract][Full Text] [Related]
4. Vascular complications with a plug-based vascular closure device after transcatheter aortic valve replacement: Predictors and bail-outs.
van Wiechen MP; Kroon H; Hokken TW; Ooms JF; de Ronde-Tillmans MJ; Daemen J; de Jaegere PP; Van Mieghem NM
Catheter Cardiovasc Interv; 2021 Nov; 98(5):E737-E745. PubMed ID: 33533544
[TBL] [Abstract][Full Text] [Related]
5. Early Outcomes After Percutaneous Closure of Access Site in Transfemoral Transcatheter Valve Implantation Using the Novel Vascular Closure Device Collagen Plug-Based MANTA.
Gheorghe L; Brouwer J; Mathijssen H; Nijenhuis VJ; Rensing BJ; Swaans MJ; Chan Pin Yin DR; Heijmen RH; De Kroon T; Sonker U; Van der Heyden JA; Ten Berg JM
Am J Cardiol; 2019 Oct; 124(8):1265-1271. PubMed ID: 31443900
[TBL] [Abstract][Full Text] [Related]
6. Successful bailout procedure for acute popliteal artery occlusion associated with EXOSEAL® vascular closure device: a case report.
Urata R; Nomura T; Hori Y; Yoshioka K; Kubota H; Miyawaki D; Sugimoto T; Kikai M; Keira N; Tatsumi T
J Med Case Rep; 2019 Mar; 13(1):90. PubMed ID: 30894201
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the MANTA Vascular Closure Device in Transfemoral TAVI.
Kmiec L; Zerdzitzki M; Schmid C; Debl K; Sossalla S; Hilker M; Holzamer A
Thorac Cardiovasc Surg; 2023 Mar; 71(2):84-93. PubMed ID: 34176110
[TBL] [Abstract][Full Text] [Related]
8. Comparison of MANTA vs ProGlide Vascular Closure Device and 30-Day Outcomes in Transfemoral Transcatheter Aortic Valve Implantation.
Eftychiou C; Eteocleous N; Mitsis A; Zittis I; Papadopoulos K; Petrou A; Adamou M; Kounnos C; Bekos C; Avraamides P
Tex Heart Inst J; 2022 Sep; 49(5):. PubMed ID: 36269884
[TBL] [Abstract][Full Text] [Related]
9. Propensity-matched comparison of vascular closure devices after transcatheter aortic valve replacement using MANTA versus ProGlide.
Moriyama N; Lindström L; Laine M
EuroIntervention; 2019 Feb; 14(15):e1558-e1565. PubMed ID: 30295293
[TBL] [Abstract][Full Text] [Related]
10. Alternative Application Technique for the MANTA Vascular Closure Device for Percutaneous Large-Bore Arterial Access Closure: The Fluoroscopic DOT Technique.
Memon S; Goldman S; Rodriguez R; Ramlawi B; Coady PM; Gnall EM
J Endovasc Ther; 2023 Dec; 30(6):885-891. PubMed ID: 35766367
[TBL] [Abstract][Full Text] [Related]
11. Angiographic Analysis of Vascular Integrity After Percutaneous Closure Using Prostar XL Device During Transcatheter Aortic Valve Implantation.
Lareyre F; Raffort J; Dommerc C; Benhammamia M; Bourlon F; Habib Y; Mialhe C
Vasc Endovascular Surg; 2017 Jul; 51(5):282-287. PubMed ID: 28474978
[TBL] [Abstract][Full Text] [Related]
12. MANTA versus ProGlide vascular closure devices in transfemoral transcatheter aortic valve implantation.
Biancari F; Romppanen H; Savontaus M; Siljander A; Mäkikallio T; Piira OP; Piuhola J; Vilkki V; Ylitalo A; Vasankari T; Airaksinen JKE; Niemelä M
Int J Cardiol; 2018 Jul; 263():29-31. PubMed ID: 29681408
[TBL] [Abstract][Full Text] [Related]
13. Comparison of vascular closure devices for access site closure after transfemoral aortic valve implantation.
Barbash IM; Barbanti M; Webb J; Molina-Martin De Nicolas J; Abramowitz Y; Latib A; Nguyen C; Deuschl F; Segev A; Sideris K; Buccheri S; Simonato M; Rosa FD; Tamburino C; Jilaihawi H; Miyazaki T; Himbert D; Schofer N; Guetta V; Bleiziffer S; Tchetche D; Immè S; Makkar RR; Vahanian A; Treede H; Lange R; Colombo A; Dvir D
Eur Heart J; 2015 Dec; 36(47):3370-9. PubMed ID: 26314688
[TBL] [Abstract][Full Text] [Related]
14. Clinical outcomes of MANTA vs suture-based vascular closure devices after transcatheter aortic valve replacement: An updated meta-analysis.
Doshi R; Vasudev R; Guragai N; Patel KN; Kumar A; Majmundar M; Doshi P; Patel P; Shah K; Santana M; Roman S; Vallabhajosyula S; Virk H; Bikkina M; Shamoon F
Indian Heart J; 2023; 75(1):59-67. PubMed ID: 36640840
[TBL] [Abstract][Full Text] [Related]
15. Transaxillary transcatheter aortic valve implantation utilizing a novel vascular closure device with resorbable collagen material: a feasibility study.
Schaefer A; Schirmer J; Schofer N; Schneeberger Y; Deuschl F; Blankenberg S; Reichenspurner H; Conradi L; Schäfer U
Clin Res Cardiol; 2019 Jul; 108(7):779-786. PubMed ID: 30560381
[TBL] [Abstract][Full Text] [Related]
16. Use of an ePTFE-covered nitinol self-expanding stent graft for the treatment off pre-closure device failure during transcatheter aortic valve replacement.
Steinvil A; Bernardo N; Rogers T; Koifman E; Buchanan K; Alraies MC; Shults C; Torguson R; Okubagzi PG; Pichard AD; Satler LF; Ben-Dor I; Waksman R
Cardiovasc Revasc Med; 2017 Mar; 18(2):128-132. PubMed ID: 27865711
[TBL] [Abstract][Full Text] [Related]
17. Ultrasound-Guided Versus Conventional MANTA Vascular Closure Device Deployment After Transcatheter Aortic Valve Implantation.
Miyashita H; Moriyama N; Dahlbacka S; Vähäsilta T; Vainikka T; Jalanko M; Viikilä J; Laine M
Am J Cardiol; 2022 Oct; 180():116-123. PubMed ID: 35933223
[TBL] [Abstract][Full Text] [Related]
18. Percutaneous access and closure using the MANTA vascular closure device in transaxillary transcatheter aortic valve implantation.
Rück A; Eriksson D; Verouhis D; Saleh N; Linder R; Corbascio M; Settergren M
EuroIntervention; 2020 Jun; 16(3):266-268. PubMed ID: 31793886
[No Abstract] [Full Text] [Related]
19. Assessment of the MANTA closure device in real-life transfemoral transcatheter aortic valve replacement: A single-centre observational study.
Boussofara A; Godin M; Canville A; Baala B; Berland J; Koning R; Landolff Q
Catheter Cardiovasc Interv; 2024 Mar; 103(4):650-659. PubMed ID: 38407552
[TBL] [Abstract][Full Text] [Related]
20. Predictable Deployment of Suture-Based Vascular Closure Device Before Transfemoral Transcatheter Aortic Valve Replacement.
Leone PP; Scotti A; Ludwig S; Sehatbakhsh S; Assafin M; Chau M; Spring A; Montesino J; Doolittle J; Granada JF; Latib A
JACC Cardiovasc Interv; 2023 Feb; 16(4):485-486. PubMed ID: 36669982
[No Abstract] [Full Text] [Related]
[Next] [New Search]
